These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 21455071)
21. Lost but making progress--Where will new analgesic drugs come from? Borsook D; Hargreaves R; Bountra C; Porreca F Sci Transl Med; 2014 Aug; 6(249):249sr3. PubMed ID: 25122640 [TBL] [Abstract][Full Text] [Related]
22. No gain, no pain: NaV1.7 as an analgesic target. King GF; Vetter I ACS Chem Neurosci; 2014 Sep; 5(9):749-51. PubMed ID: 25111714 [TBL] [Abstract][Full Text] [Related]
23. Breaking barriers to novel analgesic drug development. Yekkirala AS; Roberson DP; Bean BP; Woolf CJ Nat Rev Drug Discov; 2017 Aug; 16(8):545-564. PubMed ID: 28596533 [TBL] [Abstract][Full Text] [Related]
24. Antiepileptic drugs as analgesics/adjuvants in inflammatory pain: current preclinical evidence. Tomić M; Pecikoza U; Micov A; Vučković S; Stepanović-Petrović R Pharmacol Ther; 2018 Dec; 192():42-64. PubMed ID: 29909236 [TBL] [Abstract][Full Text] [Related]
26. Mechanisms of nerve growth factor signaling in bone nociceptors and in an animal model of inflammatory bone pain. Nencini S; Ringuet M; Kim DH; Chen YJ; Greenhill C; Ivanusic JJ Mol Pain; 2017 Jan; 13():1744806917697011. PubMed ID: 28326938 [TBL] [Abstract][Full Text] [Related]
27. A Review of the Effects of Pain and Analgesia on Immune System Function and Inflammation: Relevance for Preclinical Studies. DeMarco GJ; Nunamaker EA Comp Med; 2019 Dec; 69(6):520-534. PubMed ID: 31896389 [TBL] [Abstract][Full Text] [Related]
32. Conditioned place preference paradigm: a novel approach for analgesic drug assessment against chronic pain. Sufka KJ Pain; 1994 Sep; 58(3):355-366. PubMed ID: 7838585 [TBL] [Abstract][Full Text] [Related]
33. Issues in the future development of new analgesic drugs. David-Pereira A; Dickenson AH Curr Opin Support Palliat Care; 2019 Jun; 13(2):107-110. PubMed ID: 30883401 [TBL] [Abstract][Full Text] [Related]
34. Challenges in translational drug research in neuropathic and inflammatory pain: the prerequisites for a new paradigm. Taneja A; Della Pasqua O; Danhof M Eur J Clin Pharmacol; 2017 Oct; 73(10):1219-1236. PubMed ID: 28894907 [TBL] [Abstract][Full Text] [Related]
35. Multiple mechanisms have been tested in pain--how can we improve the chances of success? Hayes AG; Arendt-Nielsen L; Tate S Curr Opin Pharmacol; 2014 Feb; 14():11-7. PubMed ID: 24565006 [TBL] [Abstract][Full Text] [Related]
36. Recent advances in the pharmacogenomics of pain and headache. Montagna P Neurol Sci; 2007 May; 28 Suppl 2():S208-12. PubMed ID: 17508172 [TBL] [Abstract][Full Text] [Related]
37. Mining the Na Chew LA; Bellampalli SS; Dustrude ET; Khanna R Biochem Pharmacol; 2019 May; 163():9-20. PubMed ID: 30699328 [TBL] [Abstract][Full Text] [Related]
38. Understanding the genetic basis of congenital insensitivity to pain. Drissi I; Woods WA; Woods CG Br Med Bull; 2020 May; 133(1):65-78. PubMed ID: 32219415 [TBL] [Abstract][Full Text] [Related]
39. Emerging therapies in metastatic bone pain. Coluzzi F; Mandatori I; Mattia C Expert Opin Emerg Drugs; 2011 Sep; 16(3):441-58. PubMed ID: 21545247 [TBL] [Abstract][Full Text] [Related]
40. Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review. Hermanns H; Hollmann MW; Stevens MF; Lirk P; Brandenburger T; Piegeler T; Werdehausen R Br J Anaesth; 2019 Sep; 123(3):335-349. PubMed ID: 31303268 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]